British Medical Bulletin 54:243-250 (1998)
© 1998 The British Council
research-article |
Is there a rationale for eradication of Helicobacter pylori? Cost-benefit: the case for
Gastroenterology Unit, The Centre for Digestive Diseases, Leeds General Infirmary Leeds, UK
Correspondence to: prof. A T R Axon, Gastroenterology Unit, Centre for Digestive Diseases, Leeds General Infirmary, Great George St, Leeds LS1 3EX, UK
Abstract
Screening and treating the community for Helicobacter pylori would have seemed inconceivable 5 years ago. This has now become a real possibility given that H. pylori is a major risk factor for gastric carcinoma. Screening should not be introduced, however, before the costs and benefits of the programme are established. It has been estimated that 1:301:60 of the UK population die from an H. pylori related disease. If treating H. pylori were to reduce premature mortality, then this would be a persuasive argument for a screening strategy. The financial costs of screening and treating H. pylori are significant but this would be partially offset by savings that would accrue from reducing dyspepsia in the community. Indeed, decision analysis models suggest H. pylori screening is cost-effective. The potential benefits are enormous and prospective randomised trials are urgently required to establish whether such a programme is worthwhile.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J G Williams, S E Roberts, M F Ali, W Y Cheung, D R Cohen, G Demery, A Edwards, M Greer, M D Hellier, H A Hutchings, et al. Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence Gut, February 1, 2007; 56(suppl_1): 1 - 113. [Full Text] [PDF] |
||||
![]() |
P Moayyedi and J Mason Clinical and economic consequences of dyspepsia in the community Gut, May 1, 2002; 50(90004): iv10 - 12. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Moayyedi, S. Soo, J. Deeks, D. Forman, J. Mason, M. Innes, and B. Delaney Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia BMJ, September 16, 2000; 321(7262): 659 - 664. [Abstract] [Full Text] |
||||
![]() |
C. T.K.-H. Stadtlander and J. W. waterbor Molecular epidemiology, pathogenesis and prevention of gastric cancer Carcinogenesis, December 1, 1999; 20(12): 2195 - 2208. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A Stone New techniques in medicine: Non-invasive testing for Helicobacter pylori Postgrad. Med. J., February 1, 1999; 75(880): 74 - 77. [Abstract] [Full Text] |
||||



